English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine Healthcare & Pharm
T.MAN Pharmaceutical PCL (SET: TMAN) Showcases Leadership in Health Innovation, Aiming for Sustainable Growth Following Listing on SET
Oct 23, 2024 09:00 HKT
GJK Facility Services Hosts Educational Session With Dr. Chantel Thornton During Breast Cancer Awareness Week
Oct 23, 2024 07:00 HKT
Everest Medicines Announces Positive Results of Complete Chinese Subpopulation Data from the NEFECON Global Phase 3 NefIgArd Clinical Trial
Oct 22, 2024 11:52 HKT
Acrometa Group to Divest Its Life Sciences Business, Pursue New Business Opportunities in the Region
Oct 21, 2024 22:50 HKT
Everest Medicines Announces Taiwan TFDA Approval of NEFECON for the Treatment of Primary IgA Nephropathy
Oct 21, 2024 12:19 HKT
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
Oct 21, 2024 10:00 HKT
Everest Medicines' Stock Price Rises by 20% as Profit Potential Drives Valuation Recovery
Oct 18, 2024 18:37 HKT
Fosun Secures EUR670 Million for Completion of Ageas Sale
Oct 16, 2024 15:36 HKT
US Rate Cut and China Stimulus Ignite Fosun's Surge
Oct 15, 2024 11:50 HKT
CanSino Receives Another Strong Boost
Oct 09, 2024 19:29 HKT
Empower your Heart Health with LAC This World Heart Day!
Oct 09, 2024 17:30 HKT
NEFECON Included in 2024 KDIGO Clinical Practice Guidelines
Oct 02, 2024 10:18 HKT
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
Sep 25, 2024 21:00 HKT
DEXIS Digital Ecosystem Expands With Three New Innovations To Streamline and Connect Dental Workflows
Sep 24, 2024 21:30 HKT
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China
Sep 24, 2024 21:00 HKT
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
Sep 17, 2024 20:30 HKT
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
Sep 11, 2024 11:34 HKT
How Much Do Vegan Diets Improve the Health of Dogs?
Sep 06, 2024 07:00 HKT
Celeb-red our Nation's Birthday with LAC!
Aug 31, 2024 09:00 HKT
Tong Ren Tang Chinese Medicine Announces 2024 Interim Results
Aug 30, 2024 20:50 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: